Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Clinical trial NCT07176689 · RECRUITING

Trial details

NCT number: NCT07176689
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Desmoid Tumor Aggressive Fibromatosis

Start date: 2025-09-17
Primary completion: 2031-02-26
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.